Recent advances and FDA approvals in nanoformulations for drug delivery
Anahita Asadi(Howard University), Pradeep K. Karla(Howard University), Rashidat Folashade Elesho(Howard University), Kafilat Agbaje(Howard University), Onyinyechi Obidiro(Howard University), Mohammadali Kochakzade
Cited by 27
Related Papers
Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
|Pharmaceutics|2018|408
The role of vitamin D in the age of COVID‐19: A systematic review and meta‐analysis
|International Journal of Clinical Practice|2021|91
Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
|Molecular Pharmacology|2010|68
Polyamide/Poly(Amino Acid) Polymers for Drug Delivery
|Journal of Functional Biomaterials|2021|65
Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux
|International Journal of Pharmaceutics|2006|59